Sherwin Williams (SHW) Draws Valuation Focus, Is The Stock Still Undervalued?

Sherwin-Williams (SHW) is back in focus after recent share price moves, with the stock closing at $338.14. That puts fresh attention on how its current valuation lines up with fundamentals.

See our latest analysis for Sherwin-Williams.

The recent move to $338.14 comes after a 1-day share price return of 1.76% and a 30-day share price return of 4.87%. The 1-year total shareholder return of 0.41% and 5-year total shareholder return of 25.61% suggest longer term momentum has been relatively moderate compared with earlier periods.

If Sherwin-Williams has you looking beyond a single stock, this could be a good moment to see what else is setting up interestingly through 18 top founder-led companies

After this steady but not spectacular run, the question for Sherwin-Williams is whether buyers are still being paid enough for the risks they take at $338.14, once the current valuation is unpacked.

Most Popular Narrative: 9.3% Undervalued

With Sherwin-Williams at $338.14 against a widely followed fair value of $372.95, the current price sits below what that narrative models out, putting the focus on its growth and margin assumptions.

The company's sustained focus on cost control, broad and deep restructuring (doubling annual savings targets to ~$80 million), and disciplined SG&A management is structurally improving fixed cost leverage and expected to yield improved net margins and earnings power as sales volumes recover.

Read the complete narrative.

Want to see what supports that kind of valuation gap? Revenue expectations, margin rebuild and the future earnings multiple all sit at the heart of this story.

Looking for how those assumptions fit into the bigger picture for Sherwin-Williams, including its full valuation framework, cash flow modelling and risk checks? See our AI narrative and valuation for Sherwin-Williams.

Result: Fair Value of $372.95 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Sherwin-Williams still faces real tests if housing demand stays weak for longer and its heavily fixed manufacturing base continues to squeeze margins when volumes soften.

Find out about the key risks to this Sherwin-Williams narrative.

Another View: Sherwin-Williams Through the P/E Lens

While the SWS work on fair value points to Sherwin-Williams trading below intrinsic estimates, its P/E of 31.9x is much higher than the US Chemicals industry at 25.2x and well above a fair ratio of 23.1x. That richer multiple suggests less margin for error if the story wobbles from here.

For a closer look at how this price stacks up against the underlying earnings assumptions, our valuation breakdown sets out the numbers in full, including how that fair ratio was derived, in See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and concern around Sherwin-Williams, it makes sense to move quickly, review the underlying data yourself, and carefully weigh the balance of 2 key rewards and 1 important warning sign.

Looking for more Sherwin-Williams investment ideas?

If Sherwin-Williams has sharpened your focus, do not stop here. Broaden your watchlist and compare it with other compelling opportunities lined up by the Simply Wall St Screener.

• Target quality opportunities that combine solid earnings power with attractive pricing by checking the 49 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies that offer resilient payouts inside the 8 dividend fortresses.
• Prioritize stability by focusing on companies that pair robust finances with less volatile profiles using the 81 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com